phase III clinical trial


Also found in: Thesaurus, Wikipedia.
Related to phase III clinical trial: Phase 3 clinical trial, phase 2 clinical trial
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.phase III clinical trial - a large clinical trial of a treatment or drug that in phase I and phase II has been shown to be efficacious with tolerable side effects; after successful conclusion of these clinical trials it will receive formal approval from the FDA
clinical test, clinical trial - a rigorously controlled test of a new drug or a new invasive medical device on human subjects; in the United States it is conducted under the direction of the FDA before being made available for general clinical use
References in periodicals archive ?
M2 EQUITYBITES-February 18, 2019-Avapritinib wins NMPA permission to begin Phase III clinical trial of avapritinib in GIST patients in China
Global Banking News-February 18, 2019-Avapritinib wins NMPA permission to begin Phase III clinical trial of avapritinib in GIST patients in China
M2 PHARMA-February 18, 2019-Avapritinib wins NMPA permission to begin Phase III clinical trial of avapritinib in GIST patients in China
ATLANTIS is a multicenter, open-label, randomized, and controlled Phase III clinical trial that is to include 600 patients at clinical sites across 21 countries.
International Resource News-January 3, 2012--Agile Therapeutics's database locked for Phase III clinical trial of AG200-15(C)1994-2012 ENPublishing - http://www.enpublishing.co.uk
Both agencies have expressed general agreement with the proposed Phase III clinical trial with the vaccine candidate.
announced in January that it has partnered with Premier Research, a global clinical research services provider, to initiate and manage a pivotal phase III clinical trial of combination antineoplastons therapy (ANP) plus radiation therapy in children newly diagnosed with a type of brainstem tumor: diffuse intrinsic brainstem glioma (DBSG).
BioMS Medical Corp (TSX: MS), Edmonton, Canada, a leading developer of products for the treatment of multiple sclerosis (MS), has received clearance from the United States Food and Drug Administration (FDA) of its Investigational New Drug Application (IND) for the initiation of a pivotal phase III clinical trial to investigate the use of MBP8298 as a treatment for patients with secondary progressive MS.
GTx is conducting a pivotal Phase III clinical trial of ACAPODENE for the treatment of multiple serious side effects of ADT in approximately 1,400 men at over 150 sites in the United States and Mexico.
In addition, ESP and Orphan have agreed to conduct the pivotal Phase III clinical trial; prepare the New Drug Application (NDA) for submission to the US Food and Drug Administration (FDA) and pursue orphan drug designation.
As a result of the above, Teva is discontinuing the ENFORCE Phase III clinical trial program, which also includes a long-term safety study.
Bio-Thera's Phase III clinical trial will compare the safety and efficacy of BAT1806 and the reference product, Genentech's RoActemra in patients with rheumatoid arthritis.